Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Gastric Epithelial Cell Responses in Helicobacter pylori infection
Published on: July 5, 2024
Epithelial Hypusination Regulates Helicobacter pylori-induced Gastric Inflammation
Alain P Gobert1, Kara M McNamara1, Caroline V Hawkins1
1Vanderbilt University Medical Center.
Epithelial hypusination, driven by deoxyhypusine synthase (DHPS), exacerbates Helicobacter pylori-induced gastric inflammation. Inhibiting this pathway may offer a new therapeutic approach for H. pylori-associated mucosal injury.
Area of Science:
- Molecular Biology
- Gastroenterology
- Immunology
Background:
- Hypusine is a unique amino acid modification of eukaryotic initiation factor 5A (EIF5A).
- Hypusination of EIF5A is catalyzed by deoxyhypusine synthase (DHPS) and is crucial for translation.
- The role of epithelial hypusination in gastric inflammation, particularly in response to Helicobacter pylori, remains unclear.
Purpose of the Study:
- To investigate the contribution of the epithelial hypusination pathway to gastric inflammation induced by H. pylori.
- To explore the potential of targeting DHPS-dependent EIF5A hypusination as a therapeutic strategy.
Main Methods:
- Immunohistochemical analysis of DHPS and hypusinated EIF5A (EIF5A^Hyp) in human gastric biopsies.
- Generation of a mouse model with epithelial-specific deletion of Dhps (Dhps^Δepi).
- Quantitative proteomics of isolated gastric epithelial cells (GECs) from naive and infected mice.
Main Results:
- Increased DHPS and EIF5A^Hyp expression in the gastric mucosa of H. pylori-infected patients, particularly in GECs and immune cells.
- Dhps^Δepi mice showed attenuated gastric inflammation upon H. pylori infection, without affecting bacterial load.
- Proteomic analysis revealed that Dhps deletion altered protein expression related to injury and disease, and upon infection, reduced inflammatory responses in GECs.
Conclusions:
- Epithelial hypusination supports H. pylori-driven gastric inflammation by modulating inflammatory and immune responses in GECs.
- DHPS-dependent EIF5A hypusination does not influence bacterial persistence.
- Targeting DHPS could be a novel therapeutic strategy for H. pylori-associated gastric mucosal injury and disease progression.
More Related Videos
11:48Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
Published on: May 7, 2018
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy